http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I620574-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10b81289cb0a3a34c6fcd4e4728ed5eb |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-135 |
| filingDate | 2013-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7b17a03021b33574eca49858947fc1e |
| publicationDate | 2018-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I620574-B |
| titleOfInvention | Foot-and-mouth disease synthetic peptide emergency vaccine |
| abstract | The invention provides a method for synthesizing FMD peptide immunogen and its composition, and a method for detecting, treating and inhibiting FMD infection by using FMD peptide immunogen. In a specific embodiment, the present invention provides a peptide emergency vaccine for foot-and-mouth disease and a formulation thereof. The vaccine formulation of the present invention contains a mixture of FMDV VP1 protein peptides, and each peptide containing a B-cell FMDV neutralization / receptor binding epitope sequence is linked to an artificial Th epitope to promote the immunogen of each peptide. The vaccine formulation of the present invention contains a viral immunogen, and can optionally be supplemented with a mixture, homologues and functional analogues thereof having endogenous Th epitopes of FMDV. The viral peptide composition of the present invention can be made into a vaccine formula with an acceptable delivery system, which can protect pigs and cattle from FMDV attack with only one inoculation. |
| priorityDate | 2012-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.